IP Library › Granted Patent US 11,813,260
Granted Patent B1
US 11,813,260 · App. 18/202,622 · Granted Nov 14, 2023

Benzamide compounds

Inventors: Joseph Robert Pinchman (San Diego, CA); Peter Qinhua Huang (San Diego, CA); Kevin Duane Bunker (Escondido, CA); Rakesh Kumar Sit (San Diego, CA); Ahmed Abdi Samatar (San Diego, CA)
Assignee: Recurium IP Holdings, LLC
A61K31/496A61K31/5355A61K45/06C07D205/04C07D207/12C07D211/46C07D211/58C07D241/04C07D295/112C07D295/13C07D413/12C07D471/04C07D519/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,813,260
App. No.
18/202,622
Granted
Nov 14, 2023
Kind
B1
Abstract

Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as cancer and tumors, as well as viral infections such as HIV.

Claims (21)

1. A compound selected from the group consisting of:

2. The compound of claim 1 , wherein the compound is

3. The compound of claim 1 , wherein the compound is

4. The compound of claim 1 , wherein the compound is

5. The compound of claim 1 , wherein the compound is

6. The compound of claim 1 , wherein the compound is

7. The compound of claim 1 , wherein the compound is

8. The compound of claim 1 , wherein the compound is

9. The compound of claim 1 , wherein the compound is

10. The compound of claim 1 , wherein the compound is

11. A pharmaceutical composition comprising an effective amount of a compound selected from the group consisting of:

and a pharmaceutically acceptable carrier, diluent, excipient or combination thereof.

12. The pharmaceutical composition of claim 11 , wherein the compound is

13. The pharmaceutical composition of claim 11 , wherein the compound is

14. The pharmaceutical composition of claim 11 , wherein the compound is

15. The pharmaceutical composition of claim 11 , wherein the compound is

16. The pharmaceutical composition of claim 11 , wherein the compound is

17. The pharmaceutical composition of claim 11 , wherein the compound is

18. The pharmaceutical composition of claim 11 , wherein the compound is

19. The pharmaceutical composition of claim 11 , wherein the compound is

20. The pharmaceutical composition of claim 11 , wherein the compound is

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2023
From: PINCHMAN, JOSEPH ROBERT; HUANG, PETER QINHUA; BUNKER, KEVIN DUANE; SIT, RAKESH KUMAR; SAMATAR, AHMED ABDI
To: ZENO MANAGEMENT, INC.
Reel/Frame 063888/0272 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2023
From: ZENO MANAGEMENT, INC.
To: ZENO ROYALTIES & MILESTONES, LLC
Reel/Frame 063888/0281 →
CHANGE OF NAME Recorded Jun 7, 2023
From: ZENO ROYALTIES & MILESTONES, LLC
To: RECURIUM IP HOLDINGS, LLC
Reel/Frame 063915/0210 →
Continuity (3)
Continuation 17656726 · Mar 28, 2022
Division 16957861
Provisional Application 62615857 · Jan 10, 2018
Cited By (1)
US 50,643